Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
250.00
+8.24 (3.41%)
Oct 19, 2026, 10:24 AM EDT - Market open
PRAX Stock Forecast
Stock Price Forecast
According to 21 analysts polled by S&P Global, PRAX stock has a consensus rating of "Strong Buy" and an average price target of $650. The average 1-year stock price forecast is 160.00% higher than the current stock price, while the lowest is $188 (-24.80%) and the highest is $1,201 (+380.40%).
Price Target: $650 (+160.00%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 13 | 14 | 14 | 14 | 15 |
| Buy | 2 | 3 | 3 | 3 | 3 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 18 | 19 | 19 | 19 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Initiates $700 | Buy | Initiates | $700 | +180.00% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $1,201 | Buy | Maintains | $1,201 | +380.40% | Oct 15, 2026 |
| UBS | UBS | Buy Initiates $706 | Buy | Initiates | $706 | +182.40% | Oct 14, 2026 |
| BTIG | BTIG | Buy Reiterates $810 → $826 | Buy | Reiterates | $810 → $826 | +230.40% | Oct 6, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $441 → $534 | Buy | Reiterates | $441 → $534 | +113.60% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
876.86K
Revenue Next Year
345.10M
from 876.86K
Increased by 39,256.17%
EPS This Year
-14.02
from -13.48
EPS Next Year
-9.49
from -14.02
EPS and Forward PE are based on non-GAAP adjusted numbers.